Payment overview · 2025
General Payments
$541.67
8 reported records · 6 companies
Healthcare provider profile · identity verified
Deepesh S Patel, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · POUGHKEEPSIE, NY · NPI 1720022486
Verified facts
What the public records show
CMS Open Payments records show Deepesh S Patel, M.D. received $541.67 in general payments during 2025 across 8 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 27.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Symbicort by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Jardiance by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Rybelsus by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported UZEDY as an associated drug or biological on 46702 records involving 13355 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Uzedy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $150.84 | 27.9% | 3 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $125.00 | 23.1% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $124.97 | 23.1% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $92.78 | 17.1% | 1 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $26.00 | 4.8% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $22.08 | 4.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $422.18 | 7 |
| Education | $119.49 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| OFEV Normalized: ofev |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $124.97 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $92.78 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $31.35 | 2 | 2025 |
Source payment records
|
|||||
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $26.00 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $22.08 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $22.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 64 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
57 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
65 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
36 | 14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
50 | 13 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
64 | 15 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | UZEDY open payments reported associated product |
CMS Open Payments — General Payments 46702 supporting records · 13355 recipient NPIs · example record 1247244226 |
Uzedy · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1693 | 333 |
| Eliquis | Apixaban | 1641 | 189 |
| Gabapentin | Gabapentin | 1320 | 232 |
| Amlodipine Besylate | Amlodipine Besylate | 1254 | 221 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1036 | 196 |
| Furosemide | Furosemide | 1030 | 218 |
| Tamsulosin Hcl | Tamsulosin Hcl | 901 | 158 |
| Metoprolol Succinate | Metoprolol Succinate | 775 | 152 |
| Lisinopril | Lisinopril | 747 | 130 |
| Sertraline Hcl | Sertraline Hcl | 739 | 104 |
| Pantoprazole Sodium | Pantoprazole Sodium | 711 | 147 |
| Escitalopram Oxalate | Escitalopram Oxalate | 687 | 121 |
| Metformin Hcl | Metformin Hcl | 640 | 114 |
| Metoprolol Tartrate | Metoprolol Tartrate | 637 | 113 |
| Mirtazapine | Mirtazapine | 587 | 128 |
| Trazodone Hcl | Trazodone Hcl | 579 | 102 |
| Donepezil Hcl | Donepezil Hcl | 538 | 82 |
| Losartan Potassium | Losartan Potassium | 451 | 84 |
| Levetiracetam | Levetiracetam | 428 | 65 |
| Clopidogrel | Clopidogrel Bisulfate | 400 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 387 | 68 |
| Quetiapine Fumarate | Quetiapine Fumarate | 383 | 64 |
| Divalproex Sodium | Divalproex Sodium | 371 | 48 |
| Carvedilol | Carvedilol | 364 | 70 |
| Potassium Chloride | Potassium Chloride | 348 | 74 |
| Buspirone Hcl | Buspirone Hcl | 335 | 60 |
| Risperidone | Risperidone | 319 | 46 |
| Xarelto | Rivaroxaban | 307 | 33 |
| Simvastatin | Simvastatin | 306 | 55 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 300 | 39 |
| Finasteride | Finasteride | 296 | 52 |
| Omeprazole | Omeprazole | 295 | 72 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 289 | 58 |
| Rexulti | Brexpiprazole | 275 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 271 | 58 |
| Aripiprazole | Aripiprazole | 240 | 44 |
| Prednisone | Prednisone | 239 | 84 |
| Memantine Hcl | Memantine Hcl | 222 | 31 |
| Latanoprost | Latanoprost | 210 | 46 |
| Famotidine | Famotidine | 205 | 44 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 197 | 54 |
| Warfarin Sodium | Warfarin Sodium | 193 | 14 |
| Baclofen | Baclofen | 190 | 31 |
| Silver Sulfadiazine | Silver Sulfadiazine | 187 | 42 |
| Januvia | Sitagliptin Phosphate | 185 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 181 | 70 |
| Meloxicam | Meloxicam | 178 | 47 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 176 | 28 |
| Trulicity | Dulaglutide | 168 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 166 | 76 |
| Fluoxetine Hcl | Fluoxetine Hcl | 160 | 29 |
| Incruse Ellipta | Umeclidinium Bromide | 157 | 30 |
| Atenolol | Atenolol | 156 | 21 |
| Spironolactone | Spironolactone | 150 | 32 |
| Nyamyc | Nystatin | 149 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 149 | 20 |
| Sucralfate | Sucralfate | 147 | 20 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 141 | 71 |
| Torsemide | Torsemide | 141 | 36 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 137 | 48 |
| Enoxaparin Sodium | Enoxaparin Sodium | 135 | 24 |
| Lamotrigine | Lamotrigine | 135 | 23 |
| Hydralazine Hcl | Hydralazine Hcl | 133 | 33 |
| Lactulose | Lactulose | 133 | 24 |
| Midodrine Hcl | Midodrine Hcl | 133 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 131 | 28 |
| Montelukast Sodium | Montelukast Sodium | 131 | 31 |
| Entresto | Sacubitril/Valsartan | 130 | 20 |
| Olanzapine | Olanzapine | 129 | 32 |
| Sodium Chloride | 0.9 % Sodium Chloride | 126 | 72 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 41 |
| Clozapine | Clozapine | 116 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 111 | 50 |
| Topiramate | Topiramate | 111 | 15 |
| Lidocaine | Lidocaine | 110 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 109 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 107 | 26 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 107 | 26 |
| Allopurinol | Allopurinol | 104 | 27 |
| Chlorthalidone | Chlorthalidone | 103 | 18 |
| Novolog Flexpen | Insulin Aspart | 99 | 23 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 96 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 96 | 31 |
| Breo Ellipta | Fluticasone/Vilanterol | 94 | 21 |
| Myrbetriq | Mirabegron | 94 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 94 | 20 |
| Alendronate Sodium | Alendronate Sodium | 91 | 18 |
| Cefuroxime | Cefuroxime Axetil | 91 | 23 |
| Nystop | Nystatin | 91 | 37 |
| Nystatin | Nystatin | 88 | 55 |
| Digoxin | Digoxin | 86 | 14 |
| Bumetanide | Bumetanide | 85 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 85 | 24 |
| Diclofenac Sodium | Diclofenac Sodium | 81 | 39 |
| Nifedipine Er | Nifedipine | 79 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 78 | 56 |
| Ezetimibe | Ezetimibe | 78 | 19 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 77 | 75 |
| Oxcarbazepine | Oxcarbazepine | 76 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 75 | 13 |
| Metronidazole | Metronidazole | 75 | 13 |
| Ceftriaxone | Ceftriaxone Sodium | 72 | 46 |
| Doxycycline Hyclate | Doxycycline Hyclate | 72 | 61 |
| Creon | Lipase/Protease/Amylase | 71 | suppressed |
| Ketoconazole | Ketoconazole | 68 | 22 |
| Clonazepam | Clonazepam | 66 | 31 |
| Ammonium Lactate | Ammonium Lactate | 65 | 19 |
| Farxiga | Dapagliflozin Propanediol | 65 | suppressed |
| Levofloxacin | Levofloxacin | 65 | 42 |
| Methimazole | Methimazole | 64 | suppressed |
| Ozempic | Semaglutide | 64 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 12 |
| Timolol Maleate | Timolol Maleate | 62 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 61 | 23 |
| Metformin Hcl Er | Metformin Hcl | 61 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 58 | 14 |
| Ibuprofen | Ibuprofen | 58 | 14 |
| Santyl | Collagenase Clostridium Hist. | 58 | 34 |
| Tramadol Hcl | Tramadol Hcl | 58 | 37 |
| Brilinta | Ticagrelor | 57 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 56 | suppressed |
| Valsartan | Valsartan | 56 | 13 |
| Insulin Aspart Flexpen | Insulin Aspart | 55 | 18 |
| Lorazepam | Lorazepam | 55 | 29 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 54 | 20 |
| Cephalexin | Cephalexin | 53 | 42 |
| Glipizide | Glipizide | 53 | suppressed |
| Hydrocortisone | Hydrocortisone | 53 | 19 |
| Tradjenta | Linagliptin | 53 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 52 | 18 |
| Glimepiride | Glimepiride | 51 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 50 | 22 |
| Jardiance | Empagliflozin | 50 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 49 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 49 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 48 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 48 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | 12 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 46 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 45 | suppressed |
| Azithromycin | Azithromycin | 44 | 38 |
| Bupropion Xl | Bupropion Hcl | 44 | 13 |
| Dilt-Xr | Diltiazem Hcl | 44 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 43 | 14 |
| Alprazolam | Alprazolam | 42 | 26 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 42 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 42 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 42 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 42 | 11 |
| Propranolol Hcl | Propranolol Hcl | 42 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 42 | suppressed |
| Admelog Solostar | Insulin Lispro | 41 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 41 | 17 |
| Kapspargo Sprinkle | Metoprolol Succinate | 41 | suppressed |
| Letrozole | Letrozole | 41 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 41 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 41 | suppressed |
| Tetrabenazine | Tetrabenazine | 41 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 41 | 21 |
| Methocarbamol | Methocarbamol | 40 | suppressed |
| Ssd | Silver Sulfadiazine | 40 | 17 |
| Brimonidine Tartrate | Brimonidine Tartrate | 38 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 28 |
| Dorzolamide Hcl | Dorzolamide Hcl | 38 | suppressed |
| Gemtesa | Vibegron | 38 | suppressed |
| Linzess | Linaclotide | 38 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 38 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 37 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 37 | 30 |
| Meclizine Hcl | Meclizine Hcl | 37 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 36 | 13 |
| Olanzapine Odt | Olanzapine | 36 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 36 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 36 | 14 |
| Colestipol Hcl | Colestipol Hcl | 35 | suppressed |
| Glipizide Er | Glipizide | 35 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 35 | 12 |
| Sulfasalazine | Sulfasalazine | 35 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 35 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Ramipril | Ramipril | 32 | 11 |
| Celecoxib | Celecoxib | 31 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 31 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 31 | suppressed |
| Hydroxyurea | Hydroxyurea | 31 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 30 | suppressed |
| Haloperidol | Haloperidol | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Calcitriol | Calcitriol | 29 | suppressed |
| Erythromycin | Erythromycin Base | 29 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | suppressed |
| Vraylar | Cariprazine Hcl | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 28 | 12 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 28 | suppressed |
| Lumigan | Bimatoprost | 28 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Lubiprostone | Lubiprostone | 27 | suppressed |
| Multaq | Dronedarone Hcl | 27 | suppressed |
| Mupirocin | Mupirocin | 27 | 16 |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Methotrexate | Methotrexate Sodium | 26 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 26 | suppressed |
| Amantadine | Amantadine Hcl | 25 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 25 | suppressed |
| Loperamide | Loperamide Hcl | 25 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Abiraterone Acetate | Abiraterone Acetate | 24 | suppressed |
| Clonidine | Clonidine | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Abilify Maintena | Aripiprazole | 23 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 23 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 23 | suppressed |
| Pregabalin | Pregabalin | 23 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Anastrozole | Anastrozole | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | 12 |
| Procrit | Epoetin Alfa | 22 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Ingrezza | Valbenazine Tosylate | 21 | suppressed |
| Insulin Glargine Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Leflunomide | Leflunomide | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Mirabegron Er | Mirabegron | 20 | suppressed |
| Paliperidone Er | Paliperidone | 20 | suppressed |
| Rhopressa | Netarsudil Mesylate | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 19 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 18 | suppressed |
| Epinephrine | Epinephrine | 18 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 18 | suppressed |
| Alphagan P | Brimonidine Tartrate | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Cyclosporine | Cyclosporine | 17 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 17 | suppressed |
| Dulera | Mometasone/Formoterol | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 13 |
| Insulin Aspart | Insulin Aspart | 17 | suppressed |
| Meropenem | Meropenem | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 17 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 16 | suppressed |
| Dofetilide | Dofetilide | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Invokana | Canagliflozin | 16 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 16 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Alogliptin | Alogliptin Benzoate | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 12 |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Carbamazepine Er | Carbamazepine | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Uzedy | Risperidone | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Xifaxan | Rifaximin | 15 | suppressed |
| Enulose | Lactulose | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Glatiramer Acetate | Glatiramer Acetate | 14 | suppressed |
| Nadolol | Nadolol | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Ursodiol | Ursodiol | 14 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 13 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Darunavir | Darunavir | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Calcium Acetate | Calcium Acetate | 12 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 12 | suppressed |
| Corlanor | Ivabradine Hcl | 12 | suppressed |
| Epinastine Hcl | Epinastine Hcl | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Mupirocin | Mupirocin Calcium | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Ofloxacin | Ofloxacin | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Risperidone Er | Risperidone Microspheres | 12 | suppressed |
| Ritonavir | Ritonavir | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $541.67 · 8 records | Teva Pharmaceuticals USA, Inc. | AIRSUPRA, AUSTEDO XR, OFEV, OTEZLA, Omnipod, Ozempic, Rybelsus | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error